Opinion

Video

Diagnosis of Recurrent C Difficile Infections

Author(s):

Sahil Khanna, MBBS, MS

The panelist discusses how recurrent Clostridioides difficile infections involve complex differential diagnosis, including persistent infection, reinfection, and other gastrointestinal conditions. Definitive diagnosis requires molecular and immunological testing of stool samples to detect toxin genes and active toxin production.

Video content above is prompted by the following:

  • What is in your differential diagnosis when considering recurrent C difficile infections?
  • How is a definitive diagnosis made?
Related Videos
1 expert is featured in this series.
5 experts are featured in this series
Related Content
Past studies have explored the association between motor and cardiac function in younger patients with DMD, but there is a lack of research on this relationship as patients with DMD age. | Image credit: Nana_studio - stock.adobe.com
January 13th 2025

Later Loss of Ambulation Linked With Better Heart Health in DMD

Rose McNulty
The results suggest that prolonging ambulation may not adversely impact cardiac function in adulthood for patients with Duchenne muscular dystrophy (DMD).
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
The findings highlight a need for improved standardization of measurements for AAV in the context of viral vector–based gene therapies. | Image credit: RFBSIP - stock.adobe.com
January 12th 2025

Standardized Measurements Needed for AAVs in Gene Therapy, Study Finds

Rose McNulty
Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial variation in accuracy and precision.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Ovarian cancer animation | Image Credit: Dr_Microbe - stock.adobe.com
January 9th 2025

Nomogram Predicts Overall Survival in Patients With Ovarian Cancer, Liver Metastases

Brooke McCormick
Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in stability and accuracy.
Woman wearing Enfuse injector | image credit: Enable Injections
January 9th 2025

Subcutaneous Isatuximab Meets Primary End Points in Phase 3 Study for MM

Mary Caffrey
If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo